Login to Your Account



Prometheus the Latest Buy for Nestle's Health Sciences Unit

By Jennifer Boggs


Thursday, May 26, 2011
San Diego-based Prometheus Laboratories Inc., a specialty pharma and diagnostics company that has spent nearly four years in the initial public offering (IPO) queue, will become the latest acquisition of Nestle Health Sciences SA, as the Swiss firm expands its efforts in the new area of science-based nutrition.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription